JPS63273471A - Microbial strain at-25 - Google Patents

Microbial strain at-25

Info

Publication number
JPS63273471A
JPS63273471A JP8371088A JP8371088A JPS63273471A JP S63273471 A JPS63273471 A JP S63273471A JP 8371088 A JP8371088 A JP 8371088A JP 8371088 A JP8371088 A JP 8371088A JP S63273471 A JPS63273471 A JP S63273471A
Authority
JP
Japan
Prior art keywords
culture
property
negative
action
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8371088A
Other languages
Japanese (ja)
Other versions
JPH027631B2 (en
Inventor
Kiyoshi Sato
清 佐藤
Kazuhiro Inoue
井上 和泓
Hiroshi Korenaga
是永 博
Shunichiro Oga
大賀 俊一郎
Toshihiko Kumada
熊田 敏彦
Shizuo Kadoya
門矢 静夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP8371088A priority Critical patent/JPS63273471A/en
Publication of JPS63273471A publication Critical patent/JPS63273471A/en
Publication of JPH027631B2 publication Critical patent/JPH027631B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To provide a microbial strain AT-25 useful for the production of sulfated polysaccharide DF-4639 having antithrombotic action, lipoprotein lipase activating action, carcinostatic action, etc. CONSTITUTION:The objective Arthrobacter AT-25 (FERM P-1357) is a Gram-positive brevi-type bacillus positive to catalase and negative to oxidase, free from acid resistance and sporulation property, having salt resistance, unable to grow in an environment having a salt concentration of >=10%, having absolute aerobic property, non-fermentative by OF-test, negative to VP reaction, arginine decomposition property and phosphatase activity, etc. The At-25 strain is cultured in a proper medium at 25-37 deg.C and pH6.5-8.5 under aerobic condition and a sulfated polysaccharide DF-4639 having the following physical and chemical properties is separated from cultured liquid and microbial cells. Molecular weight, 23,000; specific rotation, [alpha]D<25>=-36+ or -1 deg. (C=1.0, water); molar ratios of glucose:galactose:sulfate base:phosphorus are 1.0:6.3:7.5:0.7; etc.

Description

【発明の詳細な説明】 本発明はAT−25菌に関するものである。[Detailed description of the invention] The present invention relates to AT-25 bacteria.

本発明者は、微生物生産物の中に抗血栓作用を有するも
のを探索した結果、分離番号AT−25である菌の培養
濾液及びその菌体抽出液が優れた抗血栓作用を示すこと
を見出した。その後研究を重ねた結果、本発明者は、そ
の活性本体を分離精製することに成功し、硫酸化多糖体
を主構成成分とする新規物質であることを確認した。従
来硫酸化多糖体としては動物由来のヘパリンがよく知ら
れているが、微生物によって直接に硫酸化多糖体が産生
される事実は極めて稀であり、本発明者の文献調査では
次の報告が見られるのみである。すなわち、ダービイ(
Darby)らのClostridium walch
iiの夾膜成分としてデルマタン硫酸様高分子の存在に
関する報告(J、Bacteriology、103.
159 (1970) )またはステバー(Stebe
r)らのHalococcus morrhuae菌の
細胞壁成分としてグルコース、マンノース、ガラクトー
スから成る硫酸化多糖体の報告(Archives o
f Microbiology旦5.173 (197
5))の二側に限られる。しかし、これら既報の生産菌
および産生物質は、本発明に系わるAT−25菌および
DF−4639とは、後述の如(明らかに異なるもので
ある。硫酸化多糖体DF−4639を生産するにはDF
−4839生産菌を培養すればよいが、最も代表的な方
法は、 AT−25菌またはその変異株をその菌が成育
し得る培地中で培養し、培養液または菌体から分m精製
することである。
As a result of searching for microbial products that have antithrombotic effects, the present inventor discovered that the culture filtrate and bacterial cell extract of the bacteria with isolation number AT-25 exhibited excellent antithrombotic effects. Ta. As a result of subsequent research, the present inventor succeeded in separating and purifying its active substance, and confirmed that it is a new substance whose main component is a sulfated polysaccharide. Conventionally, animal-derived heparin is well known as a sulfated polysaccharide, but the fact that sulfated polysaccharides are directly produced by microorganisms is extremely rare, and the following reports were found in the literature research conducted by the present inventor. The only thing that can be done is That is, Derby (
Clostridium walch by Darby et al.
A report on the presence of dermatan sulfate-like polymer as a capsular component of B. ii (J, Bacteriology, 103.
159 (1970)) or Stebe
(Archives o
f Microbiology 5.173 (197
5)) is limited to the two sides. However, these previously reported production bacteria and production substances are clearly different from the AT-25 bacteria and DF-4639 related to the present invention (as described later). is DF
-4839-producing bacteria may be cultured, but the most typical method is to culture AT-25 bacteria or its mutant strain in a medium in which the bacteria can grow, and then purify it from the culture solution or bacterial cells. It is.

AT−25菌は、本発明者が土壌試料から新たに分離し
た菌であり、分類学的に検討をした結果新菌種であると
推定し、暫定的にミクロコツカス属(Micrococ
cus sp、) AT−25と名付け、徹工研菌寄第
5255号として、またアルスロバクタ−属(Arth
robacter sp、)^T−25として徴工研条
菌寄第1357号として微生物工業技術研究所に寄託保
存されている。以下来園をAT−25菌と略記すること
がある。
The AT-25 bacterium is a bacterium that was newly isolated by the present inventor from a soil sample, and as a result of taxonomic examination, it was presumed to be a new bacterial species, and was tentatively classified into the genus Micrococcus.
Cus sp.
robacter sp.)^T-25 and has been deposited and preserved at the Microbial Technology Research Institute as Chokokenjo Bacteria Collection No. 1357. Hereinafter, "Virus" may be abbreviated as AT-25 bacteria.

AT−25菌の菌学的性質は次の通りである。The mycological properties of AT-25 bacteria are as follows.

a)形態 0球状乃至短稈状(培養後期に球状)、径0.5〜0.
7 Xo、7〜1.5μm、■多形性あり、■運動性な
し、■胞子形成なし、■ダラム染色陽性、■抗酸性なし b)各培地における成育状態 ■肉汁寒天平板培養 点状または円形状に中程度の発育で、光沢ある山吹茶色
を示すが、拡散性はなし。
a) Morphology 0 spherical to short culm-like (spherical in late stage of culture), diameter 0.5-0.
7. It has a medium growth in shape and shows a shiny golden brown color, but it is not diffusive.

■肉汁寒天斜面培養 糸状に成育する他は、■の平板培養の場合と同様であっ
た。
■ Meat juice agar slant culture The results were the same as in the case of plate culture in (■) except that they grew in the form of threads.

■肉汁寒天液体培養 菌膜形成はなく、全体に濁りおよび沈査あり。■Meat juice agar liquid culture There was no fungal film formation, and there was turbidity and sediment throughout.

■肉汁ゼラチン穿刺培養(22℃培養)穿刺線に沿って
成育し、かぶ状に艦化する。
■Meat juice gelatin puncture culture (culture at 22°C) Grows along the puncture line and becomes a turnip-shaped vessel.

0リドマスミルク培地 リドマスをやや赤変する。また長期培養(14日以上)
では凝固も見られる。
0 lidmus milk medium lidmus turns slightly red. Also, long-term culture (14 days or more)
Coagulation can also be seen.

C)生理学的諸性質 ■硝酸塩の還元 陰性、■脱窒反応 陰性、■MR反応
 陰性、■vp反応 陰性、■インドールの生成 なし
、■硫化水素の生成 なし、■デンプンの加水分解能 
なし、■クエン酸の利用能 なし、■無機窒素源の利用
能 あり、■水不溶性の色素生成 あり、■ウレアーゼ
作用 なし、■オキシターゼ作用 なし、[相]カタラ
ーゼ作用 あり、■生育の範囲 9)16.0〜8.5
(最適7〜8)、温度10〜37℃(最適27〜30℃
)、■好気性、■OF反応 陰性、■下記15種の糖類
からの酸およびガスの生成はなし。
C) Physiological properties ■Nitrate reduction negative, ■Denitrification reaction negative, ■MR reaction negative, ■VP reaction negative, ■Indole formation none, ■Hydrogen sulfide formation none, ■Starch hydrolysis ability
None, ■ Ability to utilize citric acid None, ■ Ability to utilize inorganic nitrogen sources, ■ Formation of water-insoluble pigments, ■ No urease action, ■ No oxidase action, [Phase] catalase action, ■ Growth range 9) 16.0-8.5
(optimum 7-8), temperature 10-37℃ (optimum 27-30℃)
), ■Aerobic, ■OF reaction negative, ■No acid or gas generation from the following 15 types of sugars.

し−アラビノース D−ガラクトース D−ソルビット
D−jP シO−ス  麦芽糖     D−マンニッ
トローグルコース  ショ糖     イノジットロー
マンノース  乳 糖     グリセリンローフラク
トース トレハロース  デンプンd)その他の諸性質 ■フォスファターゼ作用 なし、 ■アルギニンの分解能 なし、 ■塩化ナトリウム7.5*中では成育するが1峙中では
成育せず、 ■ノボビオシンおよびリゾチームに対する最小発育阻止
濃度は共に361μg/ml、 ■グアニンおよびシトシン含量(GC含量) 72.!
n。
Shi-Arabinose D-Galactose D-Sorvit D-jP ShiO-s Maltose D-Mannitol-glucose Sucrose Inojito-Romannose Lactose Glycerol Low-fructose Trehalose Starch d) Other properties ■Phosphatase action None, ■Arginine Resolution None, ■ Grows in sodium chloride 7.5* but not in sodium chloride, ■ Minimum inhibitory concentration for novobiocin and lysozyme are both 361 μg/ml, ■ Guanine and cytosine content (GC content) 72. !
n.

■菌体内色素(黄色)産生、 ■細胞壁成分にジアミノピメリン酸(DAP)あり。■Intracellular pigment (yellow) production, ■Contains diaminopimelic acid (DAP) as a cell wall component.

以上の菌学的性質を、バーシイのマニュアル(Berg
ey’s Manual of Determinat
ive Bacteriol−ogy、8th Ed、
R,E、Buchaman and N、E、Glbb
ons(Williams and Wilkins 
Co、、1974))の記載に照すと、来園はダラム陽
性の短桿菌で運動性がなく、カタラーゼ陽性、オキシタ
ーゼ陰性、抗酸性がなく胞子形成が見られない、耐塩性
はあるが、食塩10%以上含有すれば成育しえない、絶
対好気性であり、OF試験においても非醗酵的である。
The above mycological properties are explained in Bergy's manual (Berci's manual).
ey's Manual of Determinat
ive Bacteriol-ogy, 8th Ed,
R, E, Buchaman and N, E, Glbb
ons(Williams and Wilkins
According to the description by Co., 1974)), the Orchard is a Durham-positive short bacillus that is non-motile, catalase-positive, oxidase-negative, has no acid fasting properties and no spore formation, and is salt tolerant, but It cannot grow if it contains 10% or more of salt, is absolutely aerobic, and is non-fermentable in the OF test.

vP反応、アルギニン分解能およびフォスファターゼ活
性は陰性であるなどの諸性質から、アルスロバクタ−属
に属せしめるのが最も妥当である。
Due to its various properties such as negative vP reaction, negative arginine decomposition ability, and negative phosphatase activity, it is most appropriate to assign it to the genus Arthrobacter.

次に硫酸化多糖体DF−4639を得るための基本的な
方法についてのべる。すなわち、  DF−4639を
取得するために用いた菌の培養液および菌体内に0F−
4639が1積すればよいわけで、それには用いた菌が
成育しうる培地であればすべて使用可能であり、用いた
菌が責化しうる炭素源、窒素源の他に無機塩やビタミン
類を単独に、あるいは適当な割    、合に組合せて
用いることができる。炭素源としてはブドウ糖、グリセ
リンなど、窒素源としては酵母エキス、肉エキス、ペプ
トン、大豆粉、コーンステイープリカーや燐酸水素アン
モニウム、硝酸アンモニウムなどの無機アンモニウム塩
が用いられ、そのほかに無機塩としてマグネシウム、カ
リウム、鉄、マンガンなどの金属塩の適当量の添加が可
能である。また、(IF−41339は硫酸化多糖体で
あるので、硫酸ナトリウムや硫酸アンモニウムの如き硫
酸塩類を適当量加えることは極めて有意義である。培養
温度や培地のpHは使用した菌が成育しうる範囲であれ
ばよいが、温度は25〜37℃、pHは6.5〜8.5
の間で培養するのが好ましい。培養は好気的条件で行う
のがよく、例えば振盪培養法もしくは培養槽内で通気攪
拌培養を行なえばよい。
Next, the basic method for obtaining sulfated polysaccharide DF-4639 will be described. That is, 0F-
All you need is one pile of 4639, and any medium that can grow the bacteria can be used, and in addition to carbon and nitrogen sources that can be used by the bacteria, inorganic salts and vitamins can be used. They can be used alone or in appropriate proportions or combinations. Carbon sources include glucose and glycerin, nitrogen sources include yeast extract, meat extract, peptone, soybean flour, cornstarch liquor, and inorganic ammonium salts such as ammonium hydrogen phosphate and ammonium nitrate.Other inorganic salts include magnesium, Appropriate amounts of metal salts such as potassium, iron, manganese, etc. can be added. In addition, (IF-41339 is a sulfated polysaccharide, it is extremely meaningful to add an appropriate amount of sulfate such as sodium sulfate or ammonium sulfate. The culture temperature and pH of the medium should be within the range where the bacteria used can grow. Temperature: 25-37℃, pH: 6.5-8.5
It is preferable to culture between Cultivation is preferably carried out under aerobic conditions, for example by shaking culture or aerated agitation culture in a culture tank.

培養時間は24時間以上であればよいが、50〜200
時間が好ましい。
The culture time may be 24 hours or more, but the culture time may be 50 to 200 hours.
time is preferable.

培養が終了すれば、培養物を遠心分離機にかけて菌体と
濾液とに分け、濾液については大略以下に述べる如く処
理する。なお、菌体については、その量が少ない場合は
無視し得るが、多量の場合は後述する方法に従い別に処
理する。
When the culture is completed, the culture is separated into bacterial cells and a filtrate using a centrifuge, and the filtrate is treated as described below. Note that if the amount of bacterial cells is small, they can be ignored, but if the amount is large, they should be treated separately according to the method described below.

すなわち、濾液に第4級アンモニウム塩、例えばセチル
ピリジニウムクロライド(cpc )の溶液を加えて攪
拌し、生じる沈澱を高速遠心機にかけて分離して集める
。得られた沈澱に適当な濃度の電解質溶液、例えば10
零エタノール含有の3モル食塩水を加えて攪拌溶解せし
める。エタノールを新たな沈澱が生じなくなる迄加え、
生じた沈澱を集め、エタノールそしてアセトンで洗った
後乾燥すれば、粗粉末が得られる。ここに得られた粗粉
末を再び水に溶解し、稀塩酸を加えてpHを約1.0と
した後低温(約5℃)で遠心分離して不溶物を除去する
。上清を集め、希苛性ソーダ液で中和しこれに第4級ア
ンモニウム塩、例えばセチルトリメチルアンモニウムブ
ロマイド(CTAB)水溶液を加えて生じる沈澱を遠心
分離して集める。得られた沈澱を1モル食塩水中に加え
て核酸などの夾雑物を充分に攪拌可溶化した後、遠心分
離して不溶分を集める。この不溶物を1輪エタノール含
有の3モル食塩水に加えて約50℃に加温しつつ溶解す
る。この溶液にエタノールを加えて沈澱させ、生じた沈
澱を集めてエタノール、ついでアセトンで洗った後、再
び水に室温で攪拌しながら溶解させ約5℃で遠心分離し
て微量の不溶物を除去する。
That is, a solution of a quaternary ammonium salt, such as cetylpyridinium chloride (CPC), is added to the filtrate and stirred, and the resulting precipitate is separated and collected using a high-speed centrifuge. An electrolyte solution of an appropriate concentration, e.g. 10
Add 3 molar saline containing zero ethanol and stir to dissolve. Add ethanol until no new precipitate forms,
The resulting precipitate is collected, washed with ethanol and acetone, and dried to obtain a coarse powder. The resulting crude powder is dissolved in water again, diluted hydrochloric acid is added to adjust the pH to about 1.0, and then centrifuged at a low temperature (about 5° C.) to remove insoluble matter. The supernatant is collected and neutralized with a dilute caustic soda solution, and a quaternary ammonium salt such as cetyltrimethylammonium bromide (CTAB) aqueous solution is added thereto, and the resulting precipitate is collected by centrifugation. The resulting precipitate is added to 1 molar saline solution to sufficiently stir and solubilize contaminants such as nucleic acids, and then centrifuged to collect insoluble matter. This insoluble matter is added to a 3 molar saline solution containing one ring of ethanol and dissolved while heating to about 50°C. Ethanol is added to this solution to precipitate it, and the resulting precipitate is collected and washed with ethanol and then acetone, then dissolved in water again with stirring at room temperature and centrifuged at about 5°C to remove traces of insoluble matter. .

溶液に新たな沈澱が生じなくなる迄エタノールを加え、
生じた沈澱を集め、順次エタノール、アセトンおよびエ
ーテルで洗った後、約70℃で減圧乾燥すればDF−4
639が白色粉末として得られる。
Add ethanol until no new precipitate forms in the solution,
The resulting precipitate is collected, washed sequentially with ethanol, acetone, and ether, and dried under reduced pressure at about 70°C to form DF-4.
639 is obtained as a white powder.

一方、菌体からDF−4639を得るには菌体の水懸濁
液にトルエンなどを加えて室温に放置して菌体を自己融
解させ、菌体内成分を水に移行させる。
On the other hand, in order to obtain DF-4639 from bacterial cells, toluene or the like is added to an aqueous suspension of bacterial cells, and the suspension is left at room temperature to allow the bacterial cells to self-lyse, and the components within the bacterial cells are transferred to water.

この懸濁液にエタノールを4鴎になる迄加え、沈澱する
蛋白、核酸などを菌体残渣と共に濾過して除き、濾液を
濃縮してエタノールを留去する。これにcpc溶液を加
えて生じる沈澱を集め、以下培養濾液の場合と同様に処
理する。
Ethanol is added to this suspension until the suspension reaches 4 ml, precipitated proteins, nucleic acids, etc. are removed by filtration together with bacterial cell residue, and the filtrate is concentrated to remove ethanol. A CPC solution is added to this, and the resulting precipitate is collected and treated in the same manner as the culture filtrate.

上述の方法によればDF−4639は、硫酸化多糖体の
ナトリウム塩として得られ、以下の物理化学的諸性質を
有する。
According to the above method, DF-4639 is obtained as a sodium salt of a sulfated polysaccharide, and has the following physicochemical properties.

a)元素分析値、糖および蛋白含量 50ツトの値および平均値を第1表に示した。a) Elemental analysis values, sugar and protein content The 50-point values and average values are shown in Table 1.

第1表 注1)(:、A、Antonopoulos、Acta
 Chem、5cand、16,1521(1962)
に記載の方法による。
Table 1 Note 1) (:, A, Antonopoulos, Acta
Chem, 5cand, 16, 1521 (1962)
According to the method described in.

注2) P、S、Chenほか、Anal、Chem、
28.1756(195B)に記載の方法による。
Note 2) P, S, Chen et al., Anal, Chem,
According to the method described in 28.1756 (195B).

注3)フェノール−硫酸法(ガラクトース換算)注4)
ローリ−・フォリン法(牛血清アルブミン換算) b)グルコース、ガラクトース、硫酸基および燐含量モ
ル比 0F−4639を1規定硫酸中、100℃5時間加水分
解した後炭酸バリウムで中和し、Dowex 50W 
(H型)にかけて得られる流出液を用いて、Khimら
の方法(J、^m、chem、soc、、74.209
0 (1952)を適用してグルコースとガラクトース
を分離定量した。また、硫酸基および燐のモル比はSお
よびPの含量 (豹から算出した。第2表にグルコース
を1.0モルとした場合の各成分のモル比の一例を示し
た。
Note 3) Phenol-sulfuric acid method (galactose conversion) Note 4)
Lowry-Forin method (converted to bovine serum albumin) b) Glucose, galactose, sulfate groups, and phosphorus content molar ratio 0F-4639 was hydrolyzed in 1N sulfuric acid at 100°C for 5 hours, then neutralized with barium carbonate, and then dissolved in Dowex 50W.
The method of Khim et al. (J, ^m, chem, soc, 74.209
0 (1952) was applied to separate and quantify glucose and galactose. In addition, the molar ratio of sulfate groups and phosphorus is the content of S and P (calculated from leopard. Table 2 shows an example of the molar ratio of each component when glucose is 1.0 mol.

C)アミノ酸およびアミノ糖の含量モル比0F−463
9を3規定塩酸中、 100℃16時間加水分解し、塩
酸を留去してアミノ酸分析計にかけて定量した結果の一
例をグルタミン酸を1,0モルとして第3表に示した。
C) Amino acid and amino sugar content molar ratio 0F-463
9 was hydrolyzed in 3N hydrochloric acid at 100° C. for 16 hours, the hydrochloric acid was distilled off, and the results were determined using an amino acid analyzer. An example of the results is shown in Table 3, assuming 1.0 mol of glutamic acid.

d)旋光度 [α]−36± 1° (C−1,0、水)e)分子量 23.000 (デキストランを標準物質とするゲル濾
過法における主ピーク) f)紫外部吸収 2 rng/m 1水溶液において220〜340nm
に極大吸収は認められない。
d) Optical rotation [α] -36±1° (C-1,0, water) e) Molecular weight 23.000 (main peak in gel filtration method using dextran as a standard substance) f) Ultraviolet absorption 2 rng/m 1 220-340 nm in aqueous solution
No maximum absorption is observed.

g)赤外線吸収スペクトル(にBr錠)図1に示す通り
、1240.840(肩)および810cl’に硫酸化
多糖特有の吸収を示す。
g) Infrared absorption spectrum (Br tablet) As shown in Figure 1, it shows absorption specific to sulfated polysaccharides at 1240.840 (shoulder) and 810 cl'.

DF−4639の生物学的諸性質を次に示す。The biological properties of DF-4639 are shown below.

a)試験管内生物活性 注1)第一化学薬品■製品を使用 注2) ラットの血液を用いてニーグロブリン溶解時間
を測定し、最大活性を示す検体濃度を至適濃度として表
わした。
a) In vitro biological activity Note 1) Using Daiichi Chemical ■ product Note 2) Niglobulin dissolution time was measured using rat blood, and the sample concentration showing the maximum activity was expressed as the optimal concentration.

注3) ラットプラズマ画分を用いて対照の凝固時間を
2倍に延長する検体濃度を求めた。
Note 3) Using rat plasma fraction, the sample concentration that doubled the clotting time of the control was determined.

注4)牛フィブリノーゲン(シグマ社製品)及び牛トロ
ンビン(パークデービス−三共製品)を用いて凝固時間
を測定し、対照の凝固時間を2倍に延長する検体濃度を
50零阻害濃度とした。
Note 4) Clotting time was measured using bovine fibrinogen (Sigma product) and bovine thrombin (Parke Davis-Sankyo product), and the sample concentration that doubled the clotting time of the control was defined as the 50 zero inhibitory concentration.

b)ラットにおける線溶誘導活性 ラットを用い、検体投与(静注)前後のニーグロブリン
溶解時間(ELT)を経時的に測定し、次式により線溶
活性増加率(96)として表現した。
b) Fibrinolytic induction activity in rats Using rats, the knee globulin dissolution time (ELT) before and after administration of the sample (intravenous injection) was measured over time and expressed as the rate of increase in fibrinolytic activity (96) using the following formula.

C)急性毒性 LD5゜t、soomg/kg以上(マウス、静注)以
上のごとく、 0F−4639は試験管内およびラット
を用いた実験において、ヘパリンと同等もしくはそれ以
上の線溶誘導活性を示すことが確認された。しかもDF
−4639においては、好ましくない抗凝固活性がヘパ
リンに比し著しく弱いという特徴を有している。さらに
は赤血球凝集促進作用も認められず、急性毒性値も1,
500mg/kg以上(静注)であり、副作用が非常に
少なく、抗血栓薬として有望である。また、本発明者ら
は、 DF−4639にはリボプロティンリパーゼ活性
化作用、抗癌作用および感染防御作用などの有用な作用
のあることを動物実験で知見している。
C) Acute toxicity LD5゜t, somg/kg or higher (mouse, intravenous injection), indicating that 0F-4639 exhibits fibrinolytic inducing activity equivalent to or higher than heparin in in vitro and rat experiments. was confirmed. Moreover, DF
-4639 has a characteristic that its unfavorable anticoagulant activity is significantly weaker than that of heparin. Furthermore, no hemagglutination promoting effect was observed, and the acute toxicity value was 1.
It is 500 mg/kg or more (intravenous injection), has very few side effects, and is promising as an antithrombotic drug. In addition, the present inventors have found through animal experiments that DF-4639 has useful effects such as riboprotein lipase activating activity, anticancer activity, and infection prevention effect.

次に製造実施例を挙げて説明するが、机よ特に記載があ
るものを除きw/v96である。
Next, manufacturing examples will be described.The machine was w/v96 unless otherwise specified.

実施例1 グルコース2*、ペプトン0.5%F、コーンステイー
プリカー0.5机酵母エキス0.3零、食塩0.5%F
および炭酸カルシウム0.3零よりなる液体培地100
+nlを含む500m1の振盪フラスコに予め寒天斜面
培地に成育したAT−25菌の1白金耳を接種し、30
℃において3日間振盪培養して種培養液を得た。次にグ
リセリン2零、硫安0.5机燐酸−カリウム0.1k、
硫酸ナトリウム0.05k、酵母エキス0゜禽よりなる
培地20fLを301容のジャーファーメンタ−に加え
120℃で20分間滅菌したのち、pHを7.5に調整
する。
Example 1 Glucose 2*, peptone 0.5% F, cornstarch liquor 0.5, yeast extract 0.3 zero, salt 0.5% F
Liquid medium 100 consisting of and 0.3 zero of calcium carbonate
One platinum loop of AT-25 bacteria grown on an agar slant was inoculated into a 500 ml shake flask containing +nl.
A seed culture solution was obtained by culturing with shaking at ℃ for 3 days. Next, 20 glycerin, 0.5 ammonium sulfate, 0.1 k potassium phosphate,
20 fL of a culture medium consisting of 0.05 k sodium sulfate, 0 °C yeast extract, and 0° poultry was added to a 301-volume jar fermentor and sterilized at 120°C for 20 minutes, and then the pH was adjusted to 7.5.

これに種培養液600m1を接種して温度30t、通気
量毎分1i、攪拌毎分250回転の条件で159時間培
養した。得られた培養液を遠心分離して少量の菌体を除
去し、上澄?r!illに1鴎セチルピリジニウムクロ
ライド水溶液500m1を加え、−昼夜放置後、沈澱を
遠心分離した。これを3M食塩−10零(v/v)エタ
ノール溶液600m1に加え、充分に攪拌して溶解させ
た後、エタノール1.61を加えて生じた沈澱をグラス
フィルターを用いて濾別した。この沈澱をエタノール、
次いでアセトンで洗い、乾燥して粗粉末37.0gを得
た。これを500m1の水に溶解し、 0℃においてI
N塩酸で約pH1,0として生ずる沈澱を遠心分離して
除き、上清を中和後1峙セチルトリメチルアンモニウム
ブロマイド水溶液500m1を加え、生じた沈澱を遠心
分離した。沈澱を1M食塩水で充分洗った後、3M食塩
−104k(v/v)エタノール溶液150m1を加え
、充分に攪拌して溶解せしめ、エタノール450m1を
加えて一夜放置後、遠心分離して沈澱物を集めた。これ
をエタノールで洗浄後、再び水150m1に溶解せしめ
、グラスフィルターで濾過し、少量の残漬を水50m1
で洗浄した。
This was inoculated with 600 ml of seed culture solution and cultured for 159 hours at a temperature of 30 t, an aeration rate of 1 i/min, and stirring at 250 revolutions/min. The obtained culture solution is centrifuged to remove a small amount of bacterial cells, and the supernatant is r! 500 ml of an aqueous cetylpyridinium chloride solution was added to the ill, and after standing for day and night, the precipitate was centrifuged. This was added to 600 ml of a 3M salt-10 zero (v/v) ethanol solution, stirred sufficiently to dissolve, and then 1.61 ml of ethanol was added and the resulting precipitate was filtered out using a glass filter. This precipitate was mixed with ethanol,
Then, it was washed with acetone and dried to obtain 37.0 g of coarse powder. This was dissolved in 500 ml of water, and at 0°C I
The resulting precipitate was removed by centrifugation after adjusting the pH to approximately 1.0 with N-hydrochloric acid, and after neutralizing the supernatant, 500 ml of an aqueous solution of cetyltrimethylammonium bromide was added, and the resulting precipitate was centrifuged. After thoroughly washing the precipitate with 1M saline, add 150ml of 3M salt-104k (v/v) ethanol solution, stir thoroughly to dissolve, add 450ml of ethanol, leave overnight, and centrifuge to remove the precipitate. collected. After washing this with ethanol, it was dissolved again in 150 ml of water, filtered through a glass filter, and a small amount of residue was removed in 50 ml of water.
Washed with.

濾液および洗液を合し、攪拌しながらエタノール2℃中
に注ぎ、白色沈澱を生成せしめた。この沈澱をグラスフ
ィルターで濾別し、エタノール、アセトン及びエーテル
で順次洗浄し、55℃で5時間減圧乾燥し、白色粉末の
DF−4639を13.9g得た。
The filtrate and washing liquid were combined and poured into ethanol at 2° C. with stirring to form a white precipitate. This precipitate was filtered through a glass filter, washed successively with ethanol, acetone, and ether, and dried under reduced pressure at 55° C. for 5 hours to obtain 13.9 g of DF-4639 as a white powder.

本物質は、前記の物性を示すものであり、トロンビン活
性の5峙阻害濃度は0.7 μg/mlであった。
This substance exhibited the above-mentioned physical properties, and the five-pronged inhibitory concentration of thrombin activity was 0.7 μg/ml.

実施例2 グリセリン29g、可溶性でん粉1零、肉エキスl零、
ペプトン1零および食塩0.2零よりなる培地201を
301容のジャーファーメンタ−に加えて 120℃、
20分間滅菌し、実施例1と同様にして65時間培養を
行らた。培養終了後、培養液を遠心分離して、菌体と上
清に分けた。上清に 1096セチルビリジニウムクロ
ライド水溶液150m1を加え、以下実施例1に従って
分離精製して、0F−4639の白色粉末3.2gを得
た。一方、菌体は1200m1の水と 300m1のト
ルエン混合液中に懸濁し、時々攪拌しながら、室温下3
日間放置した。トルエンを減圧留去後、エタノールを約
40%F (V/V)になる迄加え、沈殿して来る蛋白
および核酸などを菌体と共に濾過して除いた。
Example 2 Glycerin 29g, soluble starch 10, meat extract 10,
A medium 201 consisting of 1 part peptone and 0.2 parts salt was added to a 301 volume jar fermentor, and heated at 120°C.
The cells were sterilized for 20 minutes and cultured for 65 hours in the same manner as in Example 1. After the culture was completed, the culture solution was centrifuged and separated into bacterial cells and supernatant. 150 ml of an aqueous solution of 1096 cetylpyridinium chloride was added to the supernatant, followed by separation and purification according to Example 1 to obtain 3.2 g of white powder of 0F-4639. On the other hand, the bacterial cells were suspended in a mixture of 1,200 ml of water and 300 ml of toluene, and incubated at room temperature for 3 minutes with occasional stirring.
I left it for days. After toluene was distilled off under reduced pressure, ethanol was added to the solution until the concentration reached about 40% F (V/V), and precipitated proteins and nucleic acids were removed by filtration together with the bacterial cells.

得られた濾液を約1℃迄に減圧下濃縮後、10%食塩水
30m1および10*セチルピリジニウムクロライド水
溶液100m1を加えて生じた沈殿を遠心分離した。以
下、実施例1に従って分i精製し、白色粉末のDF−4
639を2.4g得た。
After concentrating the obtained filtrate under reduced pressure to about 1° C., 30 ml of 10% saline and 100 ml of 10*cetylpyridinium chloride aqueous solution were added, and the resulting precipitate was centrifuged. Hereinafter, white powder DF-4 was purified in accordance with Example 1.
2.4g of 639 was obtained.

【図面の簡単な説明】[Brief explanation of drawings]

図1は赤外線吸収スペクトルである。 Figure 1 is an infrared absorption spectrum.

Claims (1)

【特許請求の範囲】[Claims] AT−25菌(微工研菌寄第5255号または微工研条
寄第1357号
AT-25 bacterium (Feikoken Bacteria No. 5255 or Fiber Science Laboratory No. 1357)
JP8371088A 1988-04-05 1988-04-05 Microbial strain at-25 Granted JPS63273471A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8371088A JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8371088A JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP14489579A Division JPS5667301A (en) 1979-11-08 1979-11-08 Sulfated polysaccharide

Publications (2)

Publication Number Publication Date
JPS63273471A true JPS63273471A (en) 1988-11-10
JPH027631B2 JPH027631B2 (en) 1990-02-20

Family

ID=13810055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8371088A Granted JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Country Status (1)

Country Link
JP (1) JPS63273471A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107988105A (en) * 2017-12-15 2018-05-04 中国科学院海洋研究所 A kind of bacillus marinus and its application
CN115895930A (en) * 2021-08-31 2023-04-04 四川大学 Salt-tolerant bacillus and application of levan produced by same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107988105A (en) * 2017-12-15 2018-05-04 中国科学院海洋研究所 A kind of bacillus marinus and its application
CN107988105B (en) * 2017-12-15 2021-06-18 中国科学院海洋研究所 Marine bacillus and application thereof
CN115895930A (en) * 2021-08-31 2023-04-04 四川大学 Salt-tolerant bacillus and application of levan produced by same
CN115895930B (en) * 2021-08-31 2023-10-31 微元合成生物技术(北京)有限公司 Salt-tolerant bacillus and application of levan produced by same

Also Published As

Publication number Publication date
JPH027631B2 (en) 1990-02-20

Similar Documents

Publication Publication Date Title
JP2571908B2 (en) Streptococcus used for production of high molecular weight sodium hyaluronate and method for selecting the same
JPH04278087A (en) New heparitinases, their production and microorganism producing the same
US3875007A (en) Lipid metabolism improving and anti-atheromatic agent
JPH068322B2 (en) Pectin manufacturing method
JP2726274B2 (en) Novel keratan sulfate degrading enzyme and microorganism and method for producing the same
JPS63273471A (en) Microbial strain at-25
JP2894293B2 (en) Galactanase S-39 and Bacillus sp. S-39 producing the same
JP3525190B2 (en) Strain producing ε-poly-L-lysine in remarkable quantity and method for producing ε-poly-L-lysine using the same
JP2000093162A (en) Culture of sporogenous lactic acid bacterium
JPH0144721B2 (en)
KR900007643B1 (en) Novel microorganism streptomyces sp.y-125
JP2801608B2 (en) Novel heparan sulfate degrading enzyme and microorganism and method for producing the same
JPH08191686A (en) Medium for producing polysaccharide and production of polysaccharide
JP3117691B1 (en) Novel heparitinase and method for producing the same
JP2548553B2 (en) Method for producing glutaminase
JP3110425B2 (en) Novel heparitinase and method for producing the same
JP3026312B2 (en) Production method of chitin degradation products
JPS58121798A (en) Polysaccharide mp-67 and its production
JPH0391478A (en) Production of collagenase
JPH072116B2 (en) Method for producing difructose and dianhydride III
JPH0823992A (en) Production of hyaluronic acid
JP2833081B2 (en) Method for producing inulotriose and / or inulotetraose
JPS6344128B2 (en)
KR830002535B1 (en) Process for preparing new biologically active substance
JPS5912274B2 (en) Method for producing an enzyme that decomposes α-1,3-glucoside bonds